Chronic Respiratory Symptoms among TB Survivors in a High-TB Burden Setting in Indonesia: A Preliminary Study
DOI:
https://doi.org/10.36497/jri.v45i3.844Keywords:
post-TB lung disease, preliminary study, respiratory symptoms, tuberculosisAbstract
Background: Tuberculosis (TB) affects over 10 million people worldwide and causes more than 1.4 million deaths in 2019. Despite improvements in TB treatment, many TB survivors experience ongoing health problems. Post-TB lung disease (PTLD) affects 30-60% of treated patients, leading to chronic respiratory impairments and reduced quality of life. Data on PTLD in Indonesia, a country with a high TB burden, are still scarce. We conducted a preliminary study in Bandung to estimate the burden of respiratory health problems among those who completed TB treatment.
Methods: Adults aged 18 years or older with a history of TB treatment and a minimum of 6 months since treatment completion were screened at two primary healthcare centres in Bandung municipality. Data on demographics, previous TB history, and clinical symptoms were collected.
Results: From 133 identified TB survivors, 61 eligible patients were interviewed. Persistent respiratory symptoms, such as cough or shortness of breath, were observed in 6 (9.8%) patients. Among these patients, some had abnormal chest x-ray and/or negative Gene Xpert MTB/RIF results.
Conclusion: Even after completing treatment, nearly 1 in 10 TB survivors experienced chronic respiratory symptoms. Greater efforts and awareness are needed to improve post-TB wellbeing, especially in high-burden settings like Indonesia.
Downloads
References
1. World Health Organization. Global tuberculosis report 2022. Geneva; 2022.
2. Menzies N, Quaife M, Allwood BW, Byrne AL, Coussens AK, Harries AD, et al. The lifetime burden of disease due to incident tuberculosis: A global re-appraisal including post-TB Ssequelae. Lancet Glob Health. 2021;9(12):e1679–87.
3. Romanowski K, Baumann B, Basham CA, Ahmad Khan F, Fox GJ, Johnston JC. Long-term all-cause mortality in people treated for tuberculosis: A systematic review and meta-analysis. Lancet Infect Dis. 2019;19(10):1129–37.
4. Quaife M, Houben RMGJ, Allwood B, Cohen T, Coussens AK, Harries AD, et al. Post-tuberculosis mortality and morbidity: Valuing the hidden epidemic. Lancet Respir Med. 2020;8(4):332–3.
5. Nightingale R, Chinoko B, Lesosky M, Rylance SJ, Mnesa B, Banda NPK, et al. Respiratory symptoms and lung function in patients treated for pulmonary tuberculosis in Malawi: A prospective cohort study. Thorax. 2022;77(11):1131–9.
6. Mpagama SG, Msaji KS, Kaswaga O, Zurba LJ, Mbelele PM, Allwood BW, et al. The burden and determinants of post-TB lung disease. International Journal of Tuberculosis and Lung Disease. 2021;25(10):846–53.
7. Meghji J, Lesosky M, Joekes E, Banda P, Rylance J, Gordon S, et al. Patient outcomes associated with post-tuberculosis lung damage in Malawi: A prospective cohort study. Thorax. 2020;75(3):269–78.
8. Ralph AP, Ardian M, Wiguna A, Maguire GP, Becker NG, Drogumuller G, et al. A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis. Thorax. 2010;65(10):863–9.
9. Mustofa S, Megantoro GK, Gozali A, Saputra TT, Sanjaya RP. Sindrom obstruksi pasca tuberkulosis dengan luluh lobus: Laporan kasus. Jurnal Ilmu Kedokteran dan Kesehatan. 2023;10(7):2426–30.
10. Amanati S, Purnomo D, Kaifa Auliya T. Efektivitas chest physiotheraphy pada sindroma obstruksi pasca tuberkulosis (SOPT) : Case report. Physiotherapy Health Science (PhysioHS). 2023;6(2):17–22.
11. Rozaliyani A, Rosianawati H, Handayani D, Agustin H, Zaini J, Syam R, et al. Chronic pulmonary aspergillosis in post tuberculosis patients in indonesia and the role of ldbio aspergillus ict as part of the diagnosis scheme. Journal of Fungi. 2020;6(4):318.
12. Dewi IMW, Fauziah N, Ekawardhani S, Andriyoko B, Adawiyah R, Hartantri Y, et al. Antibodies against Histoplasma capsulatum and Aspergillus fumigatus among chronic TB patients in Indonesia: A cross-sectional study. Med Mycol. 2023;61(5):myad036.
13. Allwood BW, Byrne A, Meghji J, Rachow A, Van Der Zalm MM, Schoch OD. Post-tuberculosis lung disease: Clinical review of an under-recognised global challenge. Respiration. 2021;100(8):751–63.
14. Gbaja-Biamila T, Bongomin F, Irurhe N, Nwosu A, Oladele R. Chronic pulmonary aspergillosis misdiagnosed as smear-negative pulmonary tuberculosis in a TB clinic in Nigeria. J Adv Med Med Res. 2018;26(10):1–5.
15. Choi YR, Yoon SH, Kim J, Yoo JY, Kim H, Jin KN. Chest radiography of tuberculosis: Determination of activity using deep learning algorithm. Tuberc Respir Dis (Seoul). 2023;86(3):226–33.
16. Daniels KJ, Irusen E, Pharaoh H, Hanekom S. Post-tuberculosis health-related quality of life, lung function and exercise capacity in a cured pulmonary tuberculosis population in the Breede Valley District, South Africa. South African Journal of Physiotherapy. 2019;75(1):1319.
17. Nightingale R, Carlin F, Meghji J, McMullen K, Evans D, van der Zalm MM, et al. Post-TB health and wellbeing. International Journal of Tuberculosis and Lung Disease. 2023;27(4):248–83.
18. Oladele RO, Irurhe NK, Foden P, Akanmu AS, Gbaja-Biamila T, Nwosu A, et al. Chronic pulmonary aspergillosis as a cause of smear-negative TB and/or TB treatment failure in Nigerians. International Journal of Tuberculosis and Lung Disease. 2017;21(9):1056–61.
19. Zulfa PO, Habibie YA. Pneumonectomy for severe post-tuberculosis bronchiectasis: A successful of case report and review of the long-term outcome. Narra J. 2023;3(3):e222.
20. Setianingrum F, Rozaliyani A, Adawiyah R, Syam R, Tugiran M, Sari CYI, et al. A prospective longitudinal study of chronic pulmonary aspergillosis in pulmonary tuberculosis in Indonesia (APICAL). Thorax. 2022;77(8):821–8.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Intan Mauli Warma Dewi, Raden Nabilah Putri Fauziyyah, Dananfi Wanda, Iceu Dimas Kulsum, Bony Wiem Lestari, Arto Yuwono Soeroto
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- The authors own the copyright of published articles. Nevertheless, Jurnal Respirologi Indonesia has the first-to-publish license for the publication material.
- Jurnal Respirologi Indonesia has the right to archive, change the format and republish published articles by presenting the authors’ names.
- Articles are published electronically for open access and online for educational, research, and archiving purposes. Jurnal Respirologi Indonesia is not responsible for any copyright issues that might emerge from using any article except for the previous three purposes.
